Impact of adding the multikinase inhibitor sorafenib to endocrine therapy in metastatic estrogen receptor-positive breast cancer.
about
Impact of adding the multikinase inhibitor sorafenib to endocrine therapy in metastatic estrogen receptor-positive breast cancer.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Impact of adding the multikina ...... ceptor-positive breast cancer.
@en
Impact of adding the multikina ...... ceptor-positive breast cancer.
@nl
type
label
Impact of adding the multikina ...... ceptor-positive breast cancer.
@en
Impact of adding the multikina ...... ceptor-positive breast cancer.
@nl
prefLabel
Impact of adding the multikina ...... ceptor-positive breast cancer.
@en
Impact of adding the multikina ...... ceptor-positive breast cancer.
@nl
P2093
P2860
P50
P921
P356
P1433
P1476
Impact of adding the multikina ...... ceptor-positive breast cancer.
@en
P2093
Esther P Black
Jessica Moss
Rouzan G Karabakhtsian
Stacey Slone
P2860
P304
P356
10.2217/FON.14.99
P407
P577
2014-12-01T00:00:00Z